Medicines and Tax Notices




4 MAY NEW ZEALAND GAZETTE 1017

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the act and are set out in the schedule hereto:

Schedule

Product:
Gemzar

Active Ingredient(s):
Gemcitabine hydrochloride 1,140mg equivalent to 1000mg Gemcitabine free base

Dosage Form:
Powder for infusion

New Zealand Sponsor:
Eli Lilly and Company (NZ) Limited

Manufacturer(s):
Lilly France SA, Fegersheim, France
Lilly Technology Center, Indianapolis, Indiana, United States of America

Product:
Gemzar

Active Ingredient(s):
Gemcitabine hydrochloride 228mg equivalent to 200mg Gemcitabine free base

Dosage Form:
Powder for infusion

New Zealand Sponsor:
Eli Lilly and Company (NZ) Limited

Manufacturer(s):
Lilly France SA, Fegersheim, France
Lilly Technology Center, Indianapolis, Indiana, United States of America

Product:
Lipitor

Active Ingredient(s):
Atorvastatin calcium 10.85mg equivalent to 10mg Atorvastatin

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Parke Davis (Div. Warner Lambert NZ Limited)

Manufacturer(s):
Godecke AG, Freiburg, Germany
Parke Davis Pharmaceuticals Limited, Vega Baja, Puerto Rico
Parke-Davis, Usine Pharmaceutique d’Angers, Angers Cedex 01, France
Warner-Lambert Company, Lititz, Pennsylvania, United States of America

Product:
Lipitor

Active Ingredient(s):
Atorvastatin calcium 21.69mg equivalent to 20mg Atorvastatin

Dosage Form:
Film coated tablet

NZ Sponsor:
Parke Davis (Div. Warner Lambert NZ Limited)

Manufacturer(s):
Godecke AG, Freiburg, Germany
Parke Davis Pharmaceuticals Limited, Vega Baja, Puerto Rico
Parke-Davis, Usine Pharmaceutique d’Angers, Angers Cedex 01, France
Warner-Lambert Company, Lititz, Pennsylvania, United States of America

Product:
Lipitor

Active Ingredient(s):
Atorvastatin calcium 43.38mg equivalent to 40mg Atorvastatin

Dosage Form:
Film coated tablet

NZ Sponsor:
Parke Davis (Div. Warner Lambert NZ Limited)

Manufacturer(s):
Godecke AG, Freiburg, Germany
Parke Davis Pharmaceuticals Limited, Vega Baja, Puerto Rico
Parke-Davis, Usine Pharmaceutique d’Angers, Angers Cedex 01, France
Warner-Lambert Company, Lititz, Pennsylvania, United States of America

Dated this 27th day of April 2000.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go3043

Inland Revenue

appear in Inland Revenue’s Tax Information Bulletin, Vol. 12, No. 5 of May 2000.

Tax Administration Act 1994

Notice of Public Ruling

  1. This is a notice of public ruling made under section 91D of the Tax Administration Act 1994.

  2. Public ruling No. 00/03 entitled “Bad debts—writing off debts as bad for GST and income tax purposes” will...

  3. A copy of the ruling may be obtained by writing to the Assistant General Manager (Adjudication & Rulings), National Office, Inland Revenue, P.O. Box 2198, Wellington.

MARTIN SMITH, General Manager (Adjudication & Rulings).

go3046



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2000, No 46


Gazette.govt.nz PDF NZ Gazette 2000, No 46





✨ LLM interpretation of page content

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
27 April 2000
Medicines, Distribution, Consent, Gemzar, Lipitor, Gemcitabine, Atorvastatin
  • G. R. Boyd, Chief Advisor, Safety and Regulation

💰 Notice of Public Ruling under Tax Administration Act 1994

💰 Finance & Revenue
Tax, Public Ruling, Bad Debts, GST, Income Tax
  • Martin Smith, General Manager (Adjudication & Rulings)